DEVICES &
DIAGNOSTICS
ConnectRx
Drug Information
CODEQUICK
Codes & Rates
ARTICLES &
EXPERTS
MDescapes
Travel & Leisure
POR Home | Diagnostics | Articles | ConnectRx | MDescapes

by IRWIN Z. ROTHENBERG, MBA, MS, CLS(ASCP) 

With emerging technological innovations in healthcare, including smartphone apps, biosensors, lab-on-a-chip, and wearable devices—all of which offer a closer connection to the patient—point-of-care (POC) technologies are quickly becoming part of the transformation of the healthcare landscape. The driving concept in support of point-of-care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field. 

by IRWIN Z. ROTHENBERG, MBA, MS, CLS(ASCP) 

The Protecting Access to Medicare Act (PAMA) includes the most extensive reform of the Medicare Clinical Laboratory Fee Schedule (CLFS) since it was established in 1984. Signed into law on April 1, 2014, PAMA was intended to introduce market-based pricing to the Medicare CLFS.  PAMA was passed after it was discovered by the Health and Human Services’ Office of Inspector General (OIG) that Medicare paid significantly more for clinical laboratory tests than commercial payers, and in some cases, Medicaid1.